Replimune Group, Inc. (REPL) P/E Ratio History
Historical price-to-earnings valuation from 2026 to 2026
Loading P/E history...
REPL Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 7, 2026, Replimune Group, Inc. (REPL) trades at a price-to-earnings ratio of -1.1x, with a stock price of $3.34 and trailing twelve-month earnings per share of $-3.42.
Compared to the Healthcare sector median P/E of 21.8x, REPL trades at a 105% discount to its sector peers. The sector includes 242 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, REPL trades at a notable discount to the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our REPL DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
REPL P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $178B | 23.1 | 7.86 | +88%Best | |
| $277B | 15.4Lowest | 0.73Best | +8% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
See REPL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs REPL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare REPL vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonREPL — Frequently Asked Questions
Quick answers to the most common questions about buying REPL stock.
Is REPL stock overvalued or undervalued?
REPL current P/E: -1.1x. 5-year average P/E: N/A. Percentile: N/A.
How does REPL's valuation compare to peers?
Replimune Group, Inc. P/E of -1.1x compares to sector median of 21.8x. The discount suggests lower growth expectations or higher risk.
What is REPL's PEG ratio?
REPL PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2026-2026.